ScholarIQanswers from OpenAlex
Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis
PaperCitations, authors & open-access status
Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis have?
ScholarIQcitation count
Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis has 288 citations in the OpenAlex counts ScholarIQ stores.
When was Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis published?
ScholarIQyear
Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis has 2018 year in the ScholarIQ index.
What is the open-access status of Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis?
ScholarIQoa status
Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis has bronze oa status in the ScholarIQ index.
What is the DOI of Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis?
ScholarIQdoi
The DOI for Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis is on the source record.
What is the PMID of Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis?
ScholarIQpmid
The PMID for Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis is on the source record.
What is the OpenAlex record for Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis?
ScholarIQopenalex
The OpenAlex for Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis is on the source record.